JNCCN 360 Logo

Launched in 2017, in partnership with the National Comprehensive Cancer Network® (NCCN®), JNCCN 360 is a comprehensive, tumor-specific online news resource geared for a broad audience of oncology professionals.

JNCCN 360 Product Image

JNCCN 360

Launched in 2017, in partnership with the National Comprehensive Cancer Network® (NCCN®), JNCCN 360 is a comprehensive, tumor-specific online news resource geared for a broad audience of oncology professionals.

With 12 tumor-specific microsites covering disease states from breast cancer to multiple myeloma, each tumor-specific microsite contains the following features:

  • JNCCN Spotlights, original feature articles on specific oncology drugs with clinical pearls from colleagues on how best to use them effectively and safely in practice
  • Latest oncology news from both major and minor medical meetings and the U.S. Food and Drug Administration
  • Key clinical trial findings and more from the medical literature
  • Videos interviews with leading experts in oncology, sharing recent study findings, clinical insights, and challenging issues
  • Site Editors who are top thought leaders in oncology and NCCN Panel Members overseeing content curation
  • Ongoing CE activities, available clinical trials, and patient resources

Website   |  Sales

Advertising

Advertising opportunities exist for individual microsites and bimonthly emailsFurther details are available in the media kit and rate card. Please contact our advertising representative with any inquiries. 

JNCCN 360 Rate Card Image

2021 JNCCN Media Kit
Media Kit


Sales Team

image

David Horowitz
VP Sales, Oncology

631-935-7652

david.horowitz@broadcastmed.com